CIK 0001661998 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 53.7 M | -6.7 M | ||
| Net income (USD) | -5.0 M | -95.8 M | ||
| Diluted EPS (USD/shares) | 2.42 | -153.96 | -0.09 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-14 | 4 | 4 | 2026-10-06 |
| 2026-10-14 | 4 | 4 | 2026-10-06 |
| 2026-10-14 | 4 | 4 | 2026-10-06 |
| 2026-10-09 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-30 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-30 |
| 2026-09-14 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-14 |
| 2026-08-27 | 4 | 4 | 2026-08-25 |
| 2026-08-27 | 4 | 4 | 2026-08-25 |
| 2026-08-27 | 4 | 4 | 2026-08-25 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-31 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-28 | EFFECT | EFFECT items ,, | |
| 2026-07-28 | 424B3 | 424B3 | |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-21 | 4/A | 4/A | 2026-06-12 |
| 2026-07-20 | SCHEDULE 13D/A | SCHEDULE 13D/A |
Forms on file (last 1,000): 4 238, 8-K 69, 3 40, 10-Q 26, SC 13G/A 16, 4/A 15, SC 13G 13, 424B3 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=QTTB (0.002 USD), /gw/filings/filings?ticker=QTTB&form=8-K, /gw/filings/facts?ticker=QTTB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange